325 related articles for article (PubMed ID: 31058995)
1. Fluorescence-Based Measurement of Real-Time Kinetics of Protoporphyrin IX After 5-Aminolevulinic Acid Administration in Human In Situ Malignant Gliomas.
Kaneko S; Suero Molina E; Ewelt C; Warneke N; Stummer W
Neurosurgery; 2019 Oct; 85(4):E739-E746. PubMed ID: 31058995
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
Kaneko S; Suero Molina E; Sporns P; Schipmann S; Black D; Stummer W
J Neurosurg; 2022 Jan; 136(1):9-15. PubMed ID: 34144512
[TBL] [Abstract][Full Text] [Related]
3. Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery.
Valdés PA; Jacobs V; Harris BT; Wilson BC; Leblond F; Paulsen KD; Roberts DW
J Neurosurg; 2015 Sep; 123(3):771-80. PubMed ID: 26140489
[TBL] [Abstract][Full Text] [Related]
4. Selective 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in Gliomas.
Ma R; Watts C
Acta Neurochir (Wien); 2016 Oct; 158(10):1935-41. PubMed ID: 27496021
[TBL] [Abstract][Full Text] [Related]
5. 5-Aminolevulinic Acid-Induced Porphyrin Contents in Various Brain Tumors: Implications Regarding Imaging Device Design and Their Validation.
Suero Molina E; Kaneko S; Black D; Stummer W
Neurosurgery; 2021 Nov; 89(6):1132-1140. PubMed ID: 34670277
[TBL] [Abstract][Full Text] [Related]
6. 5-Aminolevulinic acid-induced protoporphyrin IX levels in tissue of human malignant brain tumors.
Johansson A; Palte G; Schnell O; Tonn JC; Herms J; Stepp H
Photochem Photobiol; 2010; 86(6):1373-8. PubMed ID: 20854414
[TBL] [Abstract][Full Text] [Related]
7. Low dose 5-aminolevulinic acid: Implications in spectroscopic measurements during brain tumor surgery.
Haj-Hosseini N; Richter JC; Hallbeck M; Wårdell K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):209-14. PubMed ID: 25818546
[TBL] [Abstract][Full Text] [Related]
8. Spectroscopic measurement of 5-ALA-induced intracellular protoporphyrin IX in pediatric brain tumors.
Schwake M; Kaneko S; Suero Molina E; Müther M; Schipmann S; Köchling M; Brentrup A; Stummer W
Acta Neurochir (Wien); 2019 Oct; 161(10):2099-2105. PubMed ID: 31435824
[TBL] [Abstract][Full Text] [Related]
9. 5-Aminolevulinic Acid: Pitfalls of Fluorescence-guided Resection for Malignant Gliomas and Application for Malignant Glioma Therapy.
Yamamoto J; Kitagawa T; Miyaoka R; Suzuki K; Takamatsu S; Saito T; Nakano Y
J UOEH; 2020; 42(1):27-34. PubMed ID: 32213740
[TBL] [Abstract][Full Text] [Related]
10. Real-time in vivo kinetics of protoporphyrin IX after administration of 5-aminolevulinic acid in meningiomas and comparative analyses with glioblastomas.
Kaneko S; Brokinkel B; Suero Molina E; Warneke N; Holling M; Bunk EC; Hess K; Senner V; Paulus W; Stummer W
Acta Neurochir (Wien); 2020 Sep; 162(9):2197-2202. PubMed ID: 32361907
[TBL] [Abstract][Full Text] [Related]
11. Scanning Fiber Endoscope Improves Detection of 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence at the Boundary of Infiltrative Glioma.
Belykh E; Miller EJ; Hu D; Martirosyan NL; Woolf EC; Scheck AC; Byvaltsev VA; Nakaji P; Nelson LY; Seibel EJ; Preul MC
World Neurosurg; 2018 May; 113():e51-e69. PubMed ID: 29408716
[TBL] [Abstract][Full Text] [Related]
12. Cadherin 13 overexpression as an important factor related to the absence of tumor fluorescence in 5-aminolevulinic acid-guided resection of glioma.
Suzuki T; Wada S; Eguchi H; Adachi J; Mishima K; Matsutani M; Nishikawa R; Nishiyama M
J Neurosurg; 2013 Nov; 119(5):1331-9. PubMed ID: 24010971
[TBL] [Abstract][Full Text] [Related]
13. A Phase 1 Dose-Escalation Study of Oral 5-Aminolevulinic Acid in Adult Patients Undergoing Resection of a Newly Diagnosed or Recurrent High-Grade Glioma.
Cozzens JW; Lokaitis BC; Moore BE; Amin DV; Espinosa JA; MacGregor M; Michael AP; Jones BA
Neurosurgery; 2017 Jul; 81(1):46-55. PubMed ID: 28498936
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative 5-aminolevulinic acid-induced photodynamic diagnosis of metastatic brain tumors with histopathological analysis.
Yagi R; Kawabata S; Ikeda N; Nonoguchi N; Furuse M; Katayama Y; Kajimoto Y; Kuroiwa T
World J Surg Oncol; 2017 Sep; 15(1):179. PubMed ID: 28962578
[TBL] [Abstract][Full Text] [Related]
15. [5-Aminolevulinic acid (ALA) and its applications in neurosurgery].
Grieb P
Neurol Neurochir Pol; 2004; 38(3):201-7. PubMed ID: 15354233
[TBL] [Abstract][Full Text] [Related]
16. Characterization of plasma-derived protoporphyrin-IX-positive extracellular vesicles following 5-ALA use in patients with malignant glioma.
Jones PS; Yekula A; Lansbury E; Small JL; Ayinon C; Mordecai S; Hochberg FH; Tigges J; Delcuze B; Charest A; Ghiran I; Balaj L; Carter BS
EBioMedicine; 2019 Oct; 48():23-35. PubMed ID: 31628025
[TBL] [Abstract][Full Text] [Related]
17. Quantitative fluorescence in intracranial tumor: implications for ALA-induced PpIX as an intraoperative biomarker.
Valdés PA; Leblond F; Kim A; Harris BT; Wilson BC; Fan X; Tosteson TD; Hartov A; Ji S; Erkmen K; Simmons NE; Paulsen KD; Roberts DW
J Neurosurg; 2011 Jul; 115(1):11-7. PubMed ID: 21438658
[TBL] [Abstract][Full Text] [Related]
18. Detection improvement of gliomas in hyperspectral imaging of protoporphyrin IX fluorescence - in vitro comparison of visual identification and machine thresholds.
Lehtonen SJR; Vrzakova H; Paterno JJ; Puustinen S; Bednarik R; Hauta-Kasari M; Haneishi H; Immonen A; Jääskeläinen JE; Kämäräinen OP; Elomaa AP
Cancer Treat Res Commun; 2022; 32():100615. PubMed ID: 35905671
[TBL] [Abstract][Full Text] [Related]
19. Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas.
Stummer W; Stepp H; Wiestler OD; Pichlmeier U
Neurosurgery; 2017 Aug; 81(2):230-239. PubMed ID: 28379547
[TBL] [Abstract][Full Text] [Related]
20. Identification of PEPT2 as an important candidate molecule in 5-ALA-mediated fluorescence-guided surgery in WHO grade II/III gliomas.
Hou C; Yamaguchi S; Ishi Y; Terasaka S; Kobayashi H; Motegi H; Hatanaka KC; Houkin K
J Neurooncol; 2019 Jun; 143(2):197-206. PubMed ID: 30929128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
